These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 36163119)

  • 81. [Recent progress in leukemic stem cell research for childhood leukemia].
    Eguchi M; Eguchi-Ishimae M; Ishii E
    Rinsho Ketsueki; 2015 Oct; 56(10):1871-81. PubMed ID: 26458424
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Resistance of leukemic stem-like cells in AML cell line KG1a to natural killer cell-mediated cytotoxicity.
    She M; Niu X; Chen X; Li J; Zhou M; He Y; Le Y; Guo K
    Cancer Lett; 2012 May; 318(2):173-9. PubMed ID: 22198207
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The Therapeutic Potential of a Strategy to Prevent Acute Myeloid Leukemia Stem Cell Reprogramming in Older Patients.
    Park MN
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569414
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Molecular mechanisms for stemness maintenance of acute myeloid leukemia stem cells.
    Wang J; Wang P; Zhang T; Gao Z; Wang J; Feng M; Yin R; Zhang H
    Blood Sci; 2019 Aug; 1(1):77-83. PubMed ID: 35402786
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Role of Microenvironment in Resistance to Therapy in AML.
    Tabe Y; Konopleva M
    Curr Hematol Malig Rep; 2015 Jun; 10(2):96-103. PubMed ID: 25921386
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.
    Williams MS; Basma NJ; Amaral FMR; Wiseman DH; Somervaille TCP
    BMC Cancer; 2021 Oct; 21(1):1153. PubMed ID: 34711181
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Kindlin-3 loss curbs chronic myeloid leukemia in mice by mobilizing leukemic stem cells from protective bone marrow niches.
    Krenn PW; Koschmieder S; Fässler R
    Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24326-24335. PubMed ID: 32929022
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors.
    Venton G; Pérez-Alea M; Baier C; Fournet G; Quash G; Labiad Y; Martin G; Sanderson F; Poullin P; Suchon P; Farnault L; Nguyen C; Brunet C; Ceylan I; Costello RT
    Blood Cancer J; 2016 Sep; 6(9):e469. PubMed ID: 27611922
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia.
    Bolandi SM; Pakjoo M; Beigi P; Kiani M; Allahgholipour A; Goudarzi N; Khorashad JS; Eiring AM
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831055
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Expression of putative leukemia stem cell targets in genetically-defined acute myeloid leukemia subtypes.
    Yanagisawa B; Perkins B; Karantanos T; Levis M; Ghiaur G; Smith BD; Jones RJ
    Leuk Res; 2020 Dec; 99():106477. PubMed ID: 33220589
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Survival outcomes of CD34
    Zahran AM; Aly SS; Rayan A; El-Badawy O; Fattah MA; Ali AM; ElBadre HM; Hetta HF
    Oncotarget; 2018 Sep; 9(75):34056-34065. PubMed ID: 30344921
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Targeting histone methylation to reprogram the transcriptional state that drives survival of drug-tolerant myeloid leukemia persisters.
    van Gils N; Verhagen HJMP; Broux M; Martiáñez T; Denkers F; Vermue E; Rutten A; Csikós T; Demeyer S; Çil M; Al M; Cools J; Janssen JJWM; Ossenkoppele GJ; Menezes RX; Smit L
    iScience; 2022 Sep; 25(9):105013. PubMed ID: 36097617
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Mathematical modelling of clonal reduction therapeutic strategies in acute myeloid leukemia.
    Brunetti M; Iasenza IA; Jenner AL; Raynal NJ; Eppert K; Craig M
    Leuk Res; 2024 May; 140():107485. PubMed ID: 38579483
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells.
    Zhang L; Zhou Y; Chen K; Shi P; Li Y; Deng M; Jiang Z; Wang X; Li P; Xu B
    Target Oncol; 2017 Oct; 12(5):677-687. PubMed ID: 28710745
    [TBL] [Abstract][Full Text] [Related]  

  • 95. IGFBP7 Induces Differentiation and Loss of Survival of Human Acute Myeloid Leukemia Stem Cells without Affecting Normal Hematopoiesis.
    Verhagen HJMP; van Gils N; Martiañez T; van Rhenen A; Rutten A; Denkers F; de Leeuw DC; Smit MA; Tsui ML; de Vos Klootwijk LLE; Menezes RX; Çil M; Roemer MGM; Vermue E; Heukelom S; Zweegman S; Janssen JJWM; Ossenkoppele GJ; Schuurhuis GJ; Smit L
    Cell Rep; 2018 Dec; 25(11):3021-3035.e5. PubMed ID: 30540936
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Aberrant Lipid Metabolic Signatures in Acute Myeloid Leukemia.
    Singh P; Murali R; Shanmugam SG; Thomas S; Scott J; Warrier S; Arfuso F; Dharmarajan A; Gandhirajan RK
    Stem Cells; 2024 Mar; 42(3):200-215. PubMed ID: 38167958
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Present and Future Role of Immune Targets in Acute Myeloid Leukemia.
    Damiani D; Tiribelli M
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612249
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Flow cytometric quantification and immunophenotyping of leukemic stem cells in acute myeloid leukemia.
    Hwang K; Park CJ; Jang S; Chi HS; Kim DY; Lee JH; Lee JH; Lee KH; Im HJ; Seo JJ
    Ann Hematol; 2012 Oct; 91(10):1541-6. PubMed ID: 22669506
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Targeting ferritinophagy impairs quiescent cancer stem cells in acute myeloid leukemia in vitro and in vivo models.
    Larrue C; Mouche S; Angelino P; Sajot M; Birsen R; Kosmider O; Mckee T; Vergez F; Recher C; Mas VM; Gu Q; Xu J; Tsantoulis P; Sarry JE; Tamburini J
    Sci Transl Med; 2024 Jul; 16(757):eadk1731. PubMed ID: 39047119
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Understanding the Wnt Signaling Pathway in Acute Myeloid Leukemia Stem Cells: A Feasible Key against Relapses.
    Láinez-González D; Alonso-Aguado AB; Alonso-Dominguez JM
    Biology (Basel); 2023 May; 12(5):. PubMed ID: 37237497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.